A plaintiff in the Paxil mass tort litigation has seen her case remanded to the Philadelphia Court of Common Pleas after GlaxoSmithKline had removed the case to federal court.
The move follows the U.S. Court of Appeals for the Third Circuit's decisive opinion in June settling the long-contested question of where the pharmaceutical giant's corporate citizenship resides.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
